HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Ata Alturfan Selected Research

Coronary Artery Disease (Coronary Atherosclerosis)

1/2007The relation between plasma tissue factor and oxidized LDL levels in acute coronary syndromes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Ata Alturfan Research Topics

Disease

7Inflammation (Inflammations)
10/2023 - 11/2007
3Parkinson Disease (Parkinson's Disease)
04/2024 - 01/2023
3Obesity
03/2024 - 01/2022
3Osteoarthritis
12/2010 - 11/2007
2Hyperglycemia
03/2024 - 01/2022
2Insulin Resistance
03/2024 - 01/2022
2Body Weight (Weight, Body)
01/2022 - 01/2022
2Glucose Intolerance
01/2022 - 01/2022
2Rheumatoid Arthritis
12/2010 - 11/2007
1Gestational Diabetes (Gestational Diabetes Mellitus)
03/2024
1Congenital Abnormalities (Deformity)
10/2023
1Epilepsy (Aura)
02/2023
1Multiple Sclerosis
01/2023
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2023
1Alzheimer Disease (Alzheimer's Disease)
01/2023
1Chronic Pain
11/2022
1Pain (Aches)
11/2022
1Mitochondrial Diseases (Mitochondrial Disease)
03/2022
1Weight Gain
01/2022
1Myocardial Infarction
01/2014
1Fibrosis (Cirrhosis)
04/2012
1Arthritis (Polyarthritis)
11/2007
1Thrombosis (Thrombus)
01/2007
1Atherosclerosis
01/2007
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2007
1Acute Coronary Syndrome
01/2007
1Cardiovascular Diseases (Cardiovascular Disease)
08/2006
1Hypothyroidism
08/2006

Drug/Important Bio-Agent (IBA)

8Oxidants (Oxidizing Agents)IBA
03/2024 - 01/2007
5AntioxidantsIBA
10/2023 - 11/2007
3Thromboplastin (Tissue Factor)IBA
12/2008 - 08/2006
2Neuroprotective AgentsIBA
04/2024 - 01/2023
2Glucose (Dextrose)FDA LinkGeneric
03/2024 - 01/2022
2Morphine (MS Contin)FDA LinkGeneric
02/2023 - 11/2022
2Galectin 3 (LGALS3)IBA
01/2014 - 12/2008
2Proteins (Proteins, Gene)FDA Link
12/2010 - 11/2007
2Blood Proteins (Serum Proteins)IBA
12/2010 - 11/2007
2C-Reactive ProteinIBA
12/2010 - 12/2008
2Fibrinogen (Factor I)FDA Link
12/2008 - 08/2006
2factor VII clotting antigenIBA
12/2008 - 08/2006
1NeurotoxinsIBA
04/2024
12,5-dihydroxybenzoic acid (gentisic acid)IBA
04/2024
1Diethylhexyl Phthalate (DEHP)IBA
03/2024
1Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric
10/2023
1Brain-Derived Neurotrophic Factor (BDNF)IBA
02/2023
1Cholinergic Agents (Cholinergics)IBA
02/2023
1Pentylenetetrazole (Metrazol)IBA
02/2023
1Opioid Receptors (Opioid Receptor)IBA
02/2023
1LigandsIBA
01/2023
1erucic acidIBA
01/2023
1SynucleinsIBA
01/2023
1Vitamin KFDA Link
01/2023
1RotenoneIBA
01/2023
1Vitamin K 2 (Vitamin K2)IBA
01/2023
1Therapeutic UsesIBA
01/2023
1Analgesics (Analgesic Drugs)IBA
11/2022
1Opioid Analgesics (Opioids)IBA
11/2022
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
03/2022
13-pyridinylboronic acidIBA
03/2022
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2022
1Superoxide DismutaseIBA
01/2022
1Sweetening Agents (Sweeteners)IBA
01/2022
1Glutathione Transferase (Glutathione S-Transferase)IBA
01/2022
1Interleukin-6 (Interleukin 6)IBA
01/2022
1Blood Glucose (Blood Sugar)IBA
01/2022
1fibroblast growth factor 21IBA
01/2022
1steviosideIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2014
1CytokinesIBA
01/2014
1CollagenIBA
04/2012
1Glutathione (Reduced Glutathione)IBA
04/2012
1Peroxidase (Myeloperoxidase)IBA
04/2012
1Malondialdehyde (Propanedial)IBA
04/2012
1Sulfhydryl Compounds (Thiols)IBA
12/2010
1N-Acetylneuraminic Acid (Sialic Acid)IBA
11/2007
1oxidized low density lipoproteinIBA
01/2007
1LipidsIBA
01/2007
1Factor VII (Proconvertin)IBA
08/2006
1Factor XII (Hageman Factor)IBA
08/2006
1Hemostatics (Antihemorrhagics)IBA
08/2006

Therapy/Procedure

1Knee Replacement Arthroplasty (Total Knee Replacement)
12/2008
1Therapeutics
11/2007